Tibet Rhodiola Pharmaceutical Holding Co (600211) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.072x

Based on the latest financial reports, Tibet Rhodiola Pharmaceutical Holding Co (600211) has a cash flow conversion efficiency ratio of 0.072x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥297.86 Million ≈ $43.59 Million USD) by net assets (CN¥4.17 Billion ≈ $609.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Tibet Rhodiola Pharmaceutical Holding Co stock valuation for the company's overall valuation and market capitalisation.

Tibet Rhodiola Pharmaceutical Holding Co - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Tibet Rhodiola Pharmaceutical Holding Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tibet Rhodiola Pharmaceutical Holding Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tibet Rhodiola Pharmaceutical Holding Co ranked by their cash flow conversion efficiency. Explore Tibet Rhodiola Pharmaceutical Holding Co cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Freenome, Inc. Common stock NASDAQ:FRNM	N/A
Shenzhen Bluetrum Technology Co. Ltd. A SHG:688332	N/A
NCAB Group ST:NCAB	0.199x
Evertec Inc NYSE:EVTC	0.126x
Bob's Discount Furniture, Inc. NYSE:BOBS	0.046x
Charter Hall Long Wale REIT AU:CLW	0.027x
Sildarvinnslan Hf. IC:SVN	0.030x
Cury Construtora e Incorporadora S.A SA:CURY3	0.165x

Annual Cash Flow Conversion Efficiency for Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)

The table below shows the annual cash flow conversion efficiency of Tibet Rhodiola Pharmaceutical Holding Co from 1999 to 2025. View 600211 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥4.17 Billion ≈ $609.56 Million	CN¥1.03 Billion ≈ $150.24 Million	0.246x	-2.08%
2024-12-31	CN¥3.95 Billion ≈ $578.32 Million	CN¥994.79 Million ≈ $145.57 Million	0.252x	-21.53%
2023-12-31	CN¥3.37 Billion ≈ $493.67 Million	CN¥1.08 Billion ≈ $158.35 Million	0.321x	+16.10%
2022-12-31	CN¥3.03 Billion ≈ $443.50 Million	CN¥837.38 Million ≈ $122.53 Million	0.276x	+99.38%
2021-12-31	CN¥2.65 Billion ≈ $387.05 Million	CN¥366.53 Million ≈ $53.64 Million	0.139x	-16.23%
2020-12-31	CN¥2.59 Billion ≈ $378.76 Million	CN¥428.17 Million ≈ $62.65 Million	0.165x	-17.33%
2019-12-31	CN¥2.45 Billion ≈ $358.04 Million	CN¥489.59 Million ≈ $71.64 Million	0.200x	+56.16%
2018-12-31	CN¥2.26 Billion ≈ $330.29 Million	CN¥289.22 Million ≈ $42.32 Million	0.128x	+186.57%
2017-12-31	CN¥2.05 Billion ≈ $299.31 Million	CN¥91.46 Million ≈ $13.38 Million	0.045x	-88.24%
2016-12-31	CN¥658.19 Million ≈ $96.31 Million	CN¥250.21 Million ≈ $36.61 Million	0.380x	+37.92%
2015-12-31	CN¥485.90 Million ≈ $71.10 Million	CN¥133.93 Million ≈ $19.60 Million	0.276x	+180.74%
2014-12-31	CN¥414.18 Million ≈ $60.61 Million	CN¥-141.40 Million ≈ $-20.69 Million	-0.341x	-148.81%
2013-12-31	CN¥399.20 Million ≈ $58.42 Million	CN¥279.22 Million ≈ $40.86 Million	0.699x	+379.69%
2012-12-31	CN¥385.44 Million ≈ $56.40 Million	CN¥56.20 Million ≈ $8.22 Million	0.146x	+328.05%
2011-12-31	CN¥354.94 Million ≈ $51.94 Million	CN¥12.09 Million ≈ $1.77 Million	0.034x	+481.16%
2010-12-31	CN¥324.19 Million ≈ $47.44 Million	CN¥1.90 Million ≈ $278.05K	0.006x	-90.17%
2009-12-31	CN¥300.00 Million ≈ $43.90 Million	CN¥17.88 Million ≈ $2.62 Million	0.060x	-22.44%
2008-12-31	CN¥279.15 Million ≈ $40.85 Million	CN¥21.46 Million ≈ $3.14 Million	0.077x	+215.24%
2007-12-31	CN¥274.28 Million ≈ $40.14 Million	CN¥-18.30 Million ≈ $-2.68 Million	-0.067x	-178.61%
2006-12-31	CN¥396.34 Million ≈ $58.00 Million	CN¥33.63 Million ≈ $4.92 Million	0.085x	+76.37%
2005-12-31	CN¥393.25 Million ≈ $57.54 Million	CN¥18.92 Million ≈ $2.77 Million	0.048x	-22.12%
2004-12-31	CN¥435.51 Million ≈ $63.73 Million	CN¥26.90 Million ≈ $3.94 Million	0.062x	-44.44%
2003-12-31	CN¥424.53 Million ≈ $62.12 Million	CN¥47.20 Million ≈ $6.91 Million	0.111x	+41.76%
2002-12-31	CN¥418.85 Million ≈ $61.29 Million	CN¥32.85 Million ≈ $4.81 Million	0.078x	+106.06%
2001-12-31	CN¥406.50 Million ≈ $59.48 Million	CN¥15.47 Million ≈ $2.26 Million	0.038x	-25.49%
2000-12-31	CN¥402.35 Million ≈ $58.88 Million	CN¥20.55 Million ≈ $3.01 Million	0.051x	+786.04%
1999-12-31	CN¥389.71 Million ≈ $57.03 Million	CN¥2.25 Million ≈ $328.81K	0.006x	--

About Tibet Rhodiola Pharmaceutical Holding Co

SHG:600211 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.72 Billion

CN¥11.74 Billion CNY

Market Cap Rank

#6795 Global

#1419 in China

Share Price

CN¥36.42

Change (1 day)

-0.95%

52-Week Range

CN¥35.31 - CN¥49.22

All Time High

CN¥165.99